Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on April 30, 2025
INNEOVA Holdings Limited Strengthens Engineering Capabilities and Accelerates Growth in Sustainable Solutions with the Acquisition of INNEOVA Engineering Pte. Ltd.
GlobeNewswire
·
April 30, 2025
SINGAPORE, April 30, 2025 (GLOBE NEWSWIRE) -- INNEOVA Holdings Limited (Nasdaq: INEO, "INNEOVA Holdings" or the "Company" or the "Group"), a leading Singapore-based provider of high-quality Original Equipment Manufacturer ("OEM"), third-party branded and …
Best Testosterone Booster Supplement for Males Over 40: Why TestoPrime Leads for Muscle, Energy & Libido
GlobeNewswire
·
April 30, 2025
New York City, April 30, 2025 (GLOBE NEWSWIRE) -- Introduction: Why Testosterone Support Matters After 40 As men age, maintaining strength, stamina, and masculinity becomes increasingly difficult — and one of the biggest reasons is a steady decline in …
Kymeta Supercharges Leadership with Top Defense, Space and Tech Experts to Tackle Global Security Challenges
GlobeNewswire
·
April 30, 2025
Kymeta announces the addition of four prominent leaders to its Board of Directors and Board of Advisors The appointments come as global demand for secure, sovereign communication systems intensifies, particularly in Europe, Indo-Pacific and other allied …
Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
GlobeNewswire
·
April 30, 2025
BETHESDA, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
First AI-Driven Cognitive and Speech Therapy Platform for Spanish, English-Speaking Indian Communities
GlobeNewswire
·
April 30, 2025
LEXINGTON, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Constant Therapy Health, a pioneer in clinically proven digital AI-driven speech, language, and cognitive therapy, announces a significant expansion to its product offerings. The platform now includes …
Appendix 4C – Q3 FY25 Quarterly Cash Flow Report
GlobeNewswire
·
April 30, 2025
Highlights Reported positive topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy (MSA) led by robust clinical efficacy Phase 2 data featured in an oral presentation at the American Academy of Neurology …
BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified
GlobeNewswire
·
April 30, 2025
Phase 3 clinical data shows potential predictive biomarkers for treatment response, first identified in Phase 2 study Biomarkers could be utilized to predict and provide better patient outcomes, including response rates and survival benefits Positive …
Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting
GlobeNewswire
·
April 30, 2025
Preclinical data demonstrates unique binding location of CT-95 on mesothelin and avoidance of binding to shed mesothelin Data supports ongoing Phase 1 clinical trial for CT-95 PHILADELPHIA, April 30, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“ …
NanoXplore to Host a Webcast to Discuss Third Quarter Results on May 14th, 2025
GlobeNewswire
·
April 30, 2025
MONTREAL, April 30, 2025 (GLOBE NEWSWIRE) -- NanoXplore Inc. (“NanoXplore”) (TSX: GRA and OTCQX: NNXPF) is pleased to hold a webcast to discuss the results of its third quarter ended March 31st, 2025, on Wednesday, May 14, 2025, at 10:00 a.m. Eastern Time. …
NanoXplore organise une webdiffusion pour discuter des résultats du troisième trimestre le 14 mai 2025
GlobeNewswire
·
April 30, 2025
MONTRÉAL, 30 avr. 2025 (GLOBE NEWSWIRE) -- NanoXplore Inc. (" NanoXplore " ou la " Société ") (TSX : GRA et OTCQX : NNXPF) a le plaisir d'organiser une webdiffusion pour discuter des résultats de son troisième trimestre clos le 31 mars 2025, le mercredi 14 …
Age, previous sports experience, stronger predictors of performance in children than previous concussions, York University study finds
GlobeNewswire
·
April 30, 2025
Toronto, April 30, 2025 (GLOBE NEWSWIRE) -- A new study from York University’s Faculty of Health may offer reassuring news for parents whose children have a history of concussion, but want to get back to playing sports. Researchers from York University’s …
Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
GlobeNewswire
·
April 30, 2025
ASHBURN, Va., April 30, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company focused on the development and commercialization of therapeutic products that …
Anavex Life Sciences to Participate in The Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, …
UgoWork appoints Jean Lavigueur as Chairman of the Board to support long-term scale-up
GlobeNewswire
·
April 30, 2025
QUEBEC, April 30, 2025 (GLOBE NEWSWIRE) -- UgoWork™, a Canadian lithium-ion energy solutions provider specializing in the material handling industry, announces the appointment of Jean Lavigueur to Chairman of the Board of Directors as the company maintains …
UgoWork nomme Jean Lavigueur à la présidence du conseil d'administration pour soutenir sa croissance à long terme
GlobeNewswire
·
April 30, 2025
QUÉBEC, 30 avr. 2025 (GLOBE NEWSWIRE) -- UgoWork™, un chef de file en solutions énergétiques lithium-ion pour l’industrie de la manutention, annonce la nomination de Jean Lavigueur à la présidence de son conseil d’administration, alors que l’entreprise …
DT Midstream Reports Strong First Quarter 2025 Results
GlobeNewswire
·
April 30, 2025
DETROIT, April 30, 2025 (GLOBE NEWSWIRE) -- DT Midstream, Inc. (NYSE: DTM) today announced first quarter 2025 reported net income of $108 million, or $1.06 per diluted share. For the first quarter of 2025, Operating Earnings were $108 million, or $1.06 per …
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday, May 5, 2025, at 8:30 AM ET to discuss results for the first quarter of 2025 and provide a business outlook for …
Altimmune to Participate in the Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
GAITHERSBURG, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate in a fireside chat at the Citizens Life …
Apertura Gene Therapy and Rett Syndrome Research Trust Collaborate to Pioneer Advanced Genetic Medicines for Rett Syndrome Using TfR1-Targeted AAV Capsid
GlobeNewswire
·
April 30, 2025
NEW YORK and TRUMBULL, Conn., April 30, 2025 (GLOBE NEWSWIRE) -- Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy solutions, and the Rett Syndrome Research Trust (RSRT), an organization working to cure Rett Syndrome, today …
Stallion Uranium Announces Completion of Ground Gravity Survey over Coyote Target
GlobeNewswire
·
April 30, 2025
VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce the successful completion of a ground gravity survey over its Coyote Target, …